ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 48

$475K Total Retail Price of All Prescriptions

Rank: 7 out of 48

474 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 474 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

13% of this provider’s 474 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 10,013 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $145 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 6.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 565 556 1 6
SIMVASTATIN 537 524 2 5
HYDROCODONE-ACETAMINOPHEN 328 294 S3 3 4
WARFARIN SODIUM 300 298 4 12
OMEPRAZOLE 297 288 5 1
ATORVASTATIN CALCIUM 294 293 6 9
PRAVASTATIN SODIUM 261 258 7 20
LISINOPRIL 259 253 8 13
ALENDRONATE SODIUM 236 236 9 32
AMLODIPINE BESYLATE 227 222 10 8
FUROSEMIDE 215 211 11 7
ATENOLOL 212 208 12 24
POTASSIUM CHLORIDE 177 177 13 17
MELOXICAM 162 148 14 43
ZETIA 161 161 15 44
METOPROLOL TARTRATE 160 160 16 28
TRAMADOL HCL 155 138 17 35
HYDROCHLOROTHIAZIDE 149 148 18 23
METFORMIN HCL 146 143 19 46
LOVASTATIN 145 145 20 48
GEMFIBROZIL 130 130 21 50
CRESTOR 130 130 21 50
TAMSULOSIN HCL 119 119 23 57
LOSARTAN POTASSIUM 115 115 24 41
SERTRALINE HCL 104 104 25 59
TRIAMTERENE-HCTZ 101 99 26 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 99 27 66
DILTIAZEM ER 95 95 28 69
GABAPENTIN 91 63 29 70
DIGOXIN 90 90 30 72
DOXAZOSIN MESYLATE 88 88 31 73
ASACOL 85 85 32 10
AMITRIPTYLINE HCL 75 67 R 33 39
ENALAPRIL MALEATE 75 75 33 74
SULFASALAZINE 74 74 35 76
POLYETHYLENE GLYCOL 3350 67 62 36 32
OXYBUTYNIN CHLORIDE 66 60 37 80
METOPROLOL SUCCINATE 66 66 37 57
FAMOTIDINE 65 60 39 30
FLUTICASONE PROPIONATE 64 51 40 81
LIPITOR 63 63 41 82
ALLOPURINOL 63 63 41 82
DONEPEZIL HCL 62 62 43 85
BENAZEPRIL HCL 61 61 44 86
CARVEDILOL 60 55 45 42
DILTIAZEM 24HR CD 59 59 46 88
FLUOXETINE HCL 59 59 46 88
PREMARIN 59 45 R 46 88
FENTANYL 58 58 S2 49 91
LEVOTHROID 58 58 49 91
DIOVAN HCT 56 56 51 93
VERAPAMIL ER 50 46 52 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.